1. Dr. Ahmed bin Hamdan Aljedai (The Chairman of the Board of Director)

2.Mr. Ammar Abdulwahid Al-Khudairy

3.Eng. Adil Kareem kak Ahmed

4.Dr. Mohammad Khalil Mohammad

5.Mr. Faisal Mohammed Shaker

6. Dr. Fahad Abdulaziz Alrabiah

7. Dr. Mai Abdullah AlAjaji

8.Mr. Khalid Abdulrahman Al-Gwaiz

9.Mr. Abdulrahman Mohammed Al Thinyan

2. Mr. Khaled Abdulrahman Al-Gwaiz (The Chairman of Audit Committee)

3. Mr. Faisal Mohammed Shaker (The Chairman of Governance & Risk Committee)

4. Dr. Mai Abdullah AlAjaji (The Chairman of Nomination and Remuneration Committee)

2. The financial statements for the fiscal year ending on 31-12-2023 has been viewed and discussed.

3. Approved on the Auditor’s Report for the fiscal year ended on 31-12-2023G.

4. Approve on releasing the Board of Directors members from liability for the fiscal year ended on 31-12-2023G.

5. Approved on the Board of Directors’ decision to appoint (Ahmed bin Hamdan Al-Jadaie) as a member of the Board of Directors (independent) starting from the date of his appointment on 11/09/2023 AD to complete the Board’s session until the end of the current session on 04/02/2025 AD to succeed the Board of Directors member (Mohammed Bin Talal). Al-Nahhas - Non-Executive Board Member).

6. Approved on disbursing an amount of (4850000) riyals as a reward to members of the Board of Directors and committees for the fiscal year ending on December 31, 2023, AD.

7. Approved on delegating the authority of the General Assembly to the Board of Directors with the authorization contained in Paragraph (1) of Article Twenty-Seven (27) of the Companies Law, for a period of one year from the date of the General Assembly’s approval or until the end of the session of the delegated Board of Directors, whichever comes first, in accordance with the conditions stated in the executive regulations. The corporate system for listed joint stock companies.

8. Approved on the business and contracts concluded between the company and Al Rajhi Bank during the year 2023 AD, in which the member of the Board of Directors (Khalid bin Abdul Rahman Al-Quwaiz) has an indirect interest, which is (providing short-term financing facilities and promissory notes worth 250 million Saudi riyals for a period of one year without Preferential terms and conditions).

9. Approved on the business and contracts concluded between the company and Riyad Bank during the year 2023 AD, in which the former Chairman of the Board of Directors (Mohammed bin Talal Al-Nahhas) has an indirect interest, which are (contracts to provide Islamic financing and financial means for each of them for a period of one year without preferential terms and conditions).) In the amount of (950) Saudi riyals.

10. Approved on the business and contracts concluded between the company and Dammam Pharma, which is one of the subsidiaries of Spimaco Pharmaceutical Company, in which the former Chairman of the Board of Directors (Mohammed bin Talal Al-Nahhas) has an indirect interest, which is (providing manufacturing services to the company without conditions for a period of one year). During the year 2023 AD) in the amount of (11,052,649) Saudi riyals.

11. Approved on the business and contracts concluded between the company and Dammam Pharma, one of the subsidiaries of Spimaco Pharmaceutical Company, in which the former Chairman of the Board of Directors (Mohammed bin Talal Al-Nahhas) has an indirect interest, which is (providing pharmaceutical products to the company without conditions and for a period of one year during 2023 AD) in the amount of (18,051,948) Saudi riyals.

12. Approved on the amendments on the remuneration policy for members of the Board of Directors, the committees emanating from the Board, the executive management, and the company’s representatives on the boards of directors of subsidiaries.

13. Approved on the amendments on Article No. (20) of the company’s bylaws relating to (Powers of the Board of Directors).

14. Approved on the amendments on Article No. (22) of the company’s bylaws, relating to (Powers of the President, Deputy, managing director and Board Secretary).